Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cervical Vertebrae | 50 | 2019 | 969 | 7.960 |
Why?
|
Spinal Fusion | 49 | 2022 | 1238 | 4.860 |
Why?
|
Spinal Diseases | 29 | 2021 | 538 | 4.490 |
Why?
|
Lumbar Vertebrae | 33 | 2021 | 1863 | 3.020 |
Why?
|
Range of Motion, Articular | 21 | 2019 | 1591 | 2.660 |
Why?
|
Orthopedic Procedures | 15 | 2023 | 1295 | 2.620 |
Why?
|
Spine | 15 | 2022 | 1127 | 1.920 |
Why?
|
Decompression, Surgical | 15 | 2019 | 608 | 1.860 |
Why?
|
Spinal Stenosis | 11 | 2021 | 264 | 1.780 |
Why?
|
Orthopedics | 8 | 2023 | 921 | 1.770 |
Why?
|
Diskectomy | 15 | 2021 | 202 | 1.360 |
Why?
|
Zygapophyseal Joint | 5 | 2016 | 135 | 1.340 |
Why?
|
Extracellular Matrix | 9 | 2024 | 1747 | 1.210 |
Why?
|
Vertebral Artery | 4 | 2013 | 195 | 1.210 |
Why?
|
Spinal Neoplasms | 7 | 2022 | 706 | 1.180 |
Why?
|
Arthrodesis | 6 | 2022 | 190 | 1.140 |
Why?
|
Postoperative Complications | 26 | 2022 | 15459 | 1.130 |
Why?
|
Low Back Pain | 9 | 2023 | 965 | 1.110 |
Why?
|
Laminectomy | 7 | 2017 | 232 | 1.090 |
Why?
|
Rabbits | 25 | 2021 | 4910 | 1.040 |
Why?
|
Bone Morphogenetic Protein 2 | 7 | 2012 | 353 | 1.010 |
Why?
|
Radiculopathy | 9 | 2014 | 194 | 0.950 |
Why?
|
Rotation | 5 | 2016 | 528 | 0.940 |
Why?
|
Internship and Residency | 4 | 2023 | 5858 | 0.850 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 6 | 2021 | 148 | 0.850 |
Why?
|
Biological Products | 3 | 2023 | 881 | 0.830 |
Why?
|
Movement | 7 | 2016 | 1478 | 0.820 |
Why?
|
Intraoperative Complications | 5 | 2019 | 1206 | 0.810 |
Why?
|
Lumbosacral Region | 4 | 2019 | 309 | 0.800 |
Why?
|
Punctures | 2 | 2015 | 375 | 0.790 |
Why?
|
Sciatica | 2 | 2020 | 98 | 0.750 |
Why?
|
Genetic Vectors | 14 | 2011 | 3417 | 0.740 |
Why?
|
Adenoviridae | 10 | 2008 | 1101 | 0.730 |
Why?
|
Stress, Mechanical | 5 | 2024 | 1687 | 0.710 |
Why?
|
Gene Transfer Techniques | 9 | 2011 | 1222 | 0.660 |
Why?
|
Extracellular Matrix Proteins | 5 | 2015 | 855 | 0.650 |
Why?
|
Hydrostatic Pressure | 4 | 2024 | 108 | 0.640 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2019 | 284 | 0.620 |
Why?
|
Weight-Bearing | 5 | 2015 | 534 | 0.610 |
Why?
|
Transforming Growth Factor beta | 8 | 2012 | 2005 | 0.600 |
Why?
|
Longitudinal Ligaments | 1 | 2017 | 26 | 0.590 |
Why?
|
Ligamentum Flavum | 2 | 2016 | 17 | 0.590 |
Why?
|
Head Movements | 2 | 2015 | 150 | 0.590 |
Why?
|
Neurosurgical Procedures | 8 | 2021 | 2028 | 0.570 |
Why?
|
Dura Mater | 5 | 2020 | 290 | 0.570 |
Why?
|
Vascular System Injuries | 3 | 2020 | 250 | 0.540 |
Why?
|
Paralysis | 1 | 2017 | 249 | 0.520 |
Why?
|
Bone Morphogenetic Proteins | 5 | 2008 | 842 | 0.520 |
Why?
|
Esophageal Perforation | 1 | 2015 | 70 | 0.510 |
Why?
|
Sacrum | 3 | 2017 | 281 | 0.510 |
Why?
|
Humans | 168 | 2023 | 752741 | 0.510 |
Why?
|
Proteoglycans | 9 | 2012 | 834 | 0.500 |
Why?
|
Internal Fixators | 2 | 2006 | 188 | 0.500 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 691 | 0.500 |
Why?
|
Fibula | 2 | 2009 | 273 | 0.490 |
Why?
|
Needles | 3 | 2015 | 451 | 0.490 |
Why?
|
Inflammation Mediators | 4 | 2015 | 1901 | 0.480 |
Why?
|
Mesenchymal Stem Cells | 3 | 2011 | 1658 | 0.470 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2011 | 512 | 0.470 |
Why?
|
Dependovirus | 3 | 2011 | 702 | 0.470 |
Why?
|
Radiography | 17 | 2013 | 7047 | 0.470 |
Why?
|
Joint Capsule | 1 | 2014 | 68 | 0.470 |
Why?
|
Dinoprostone | 6 | 2010 | 600 | 0.460 |
Why?
|
Spinal Cord Diseases | 5 | 2017 | 290 | 0.460 |
Why?
|
Hypesthesia | 1 | 2014 | 108 | 0.460 |
Why?
|
Adult | 73 | 2023 | 216658 | 0.450 |
Why?
|
Paresthesia | 1 | 2014 | 161 | 0.440 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2013 | 98 | 0.440 |
Why?
|
Cells, Cultured | 21 | 2024 | 19270 | 0.430 |
Why?
|
Pain, Postoperative | 7 | 2021 | 1678 | 0.420 |
Why?
|
Atlanto-Axial Joint | 2 | 2011 | 61 | 0.420 |
Why?
|
Blood Transfusion, Autologous | 3 | 2008 | 133 | 0.420 |
Why?
|
Cell Transplantation | 2 | 2013 | 478 | 0.420 |
Why?
|
Middle Aged | 72 | 2023 | 216054 | 0.410 |
Why?
|
Aging | 8 | 2020 | 8752 | 0.410 |
Why?
|
Computer Graphics | 1 | 2014 | 360 | 0.410 |
Why?
|
Mechanical Phenomena | 1 | 2013 | 141 | 0.400 |
Why?
|
Bone Transplantation | 6 | 2016 | 910 | 0.400 |
Why?
|
Abscess | 1 | 2015 | 609 | 0.400 |
Why?
|
Spinal Nerve Roots | 1 | 2012 | 121 | 0.400 |
Why?
|
Umbilical Cord | 1 | 2013 | 184 | 0.400 |
Why?
|
Matrix Metalloproteinases | 2 | 2016 | 394 | 0.390 |
Why?
|
Osteophyte | 1 | 2011 | 44 | 0.390 |
Why?
|
Pseudarthrosis | 3 | 2011 | 58 | 0.390 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2014 | 717 | 0.390 |
Why?
|
Female | 92 | 2023 | 385090 | 0.380 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2012 | 122 | 0.370 |
Why?
|
Osseointegration | 2 | 2011 | 275 | 0.370 |
Why?
|
Brachial Plexus | 1 | 2012 | 164 | 0.360 |
Why?
|
Thoracic Vertebrae | 3 | 2012 | 601 | 0.360 |
Why?
|
Fellowships and Scholarships | 3 | 2023 | 1101 | 0.360 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2021 | 1486 | 0.360 |
Why?
|
Notochord | 1 | 2009 | 37 | 0.350 |
Why?
|
Male | 82 | 2023 | 354311 | 0.350 |
Why?
|
Retrospective Studies | 39 | 2023 | 78758 | 0.350 |
Why?
|
Blood Loss, Surgical | 3 | 2012 | 658 | 0.350 |
Why?
|
Pain Measurement | 6 | 2014 | 3469 | 0.350 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1498 | 0.350 |
Why?
|
Osteoarthritis | 3 | 2008 | 1049 | 0.340 |
Why?
|
Subdural Effusion | 2 | 2008 | 19 | 0.340 |
Why?
|
DNA, Complementary | 3 | 2008 | 2037 | 0.340 |
Why?
|
Spondylolysis | 1 | 2008 | 40 | 0.330 |
Why?
|
Animals | 51 | 2024 | 169600 | 0.320 |
Why?
|
Pain | 4 | 2011 | 5040 | 0.320 |
Why?
|
Transgenes | 3 | 2021 | 1012 | 0.310 |
Why?
|
Spinal Fractures | 3 | 2005 | 695 | 0.310 |
Why?
|
Joint Prosthesis | 1 | 2009 | 258 | 0.310 |
Why?
|
Cytokines | 5 | 2012 | 7400 | 0.310 |
Why?
|
Osteoarthritis, Hip | 1 | 2012 | 416 | 0.310 |
Why?
|
Biomedical Research | 1 | 2023 | 3349 | 0.300 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2011 | 365 | 0.300 |
Why?
|
Natural Language Processing | 3 | 2020 | 1059 | 0.300 |
Why?
|
Education, Medical, Graduate | 4 | 2023 | 2322 | 0.300 |
Why?
|
Bupivacaine | 1 | 2011 | 414 | 0.290 |
Why?
|
Patient Readmission | 2 | 2018 | 3161 | 0.290 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2007 | 45 | 0.290 |
Why?
|
Titanium | 2 | 2009 | 493 | 0.290 |
Why?
|
Aggrecans | 5 | 2024 | 90 | 0.290 |
Why?
|
Robotics | 2 | 2013 | 890 | 0.290 |
Why?
|
Exudates and Transudates | 1 | 2007 | 176 | 0.290 |
Why?
|
Tetracycline | 1 | 2007 | 216 | 0.280 |
Why?
|
Matrix Metalloproteinase 3 | 5 | 2015 | 133 | 0.280 |
Why?
|
Osteolysis | 1 | 2008 | 269 | 0.280 |
Why?
|
Suture Anchors | 1 | 2007 | 78 | 0.280 |
Why?
|
Metalloendopeptidases | 3 | 1997 | 404 | 0.270 |
Why?
|
Interleukin-1 | 3 | 2008 | 1262 | 0.270 |
Why?
|
Aged | 45 | 2021 | 165629 | 0.270 |
Why?
|
Esophagus | 1 | 2011 | 1033 | 0.260 |
Why?
|
Macrophage Activation | 1 | 2008 | 566 | 0.260 |
Why?
|
Tomography, X-Ray Computed | 7 | 2018 | 20346 | 0.260 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4733 | 0.250 |
Why?
|
Prosthesis Design | 4 | 2009 | 2127 | 0.250 |
Why?
|
Joint Instability | 3 | 2009 | 801 | 0.250 |
Why?
|
Nitric Oxide | 5 | 2008 | 2152 | 0.250 |
Why?
|
United States | 16 | 2023 | 70772 | 0.250 |
Why?
|
Medicare | 3 | 2021 | 6670 | 0.250 |
Why?
|
Patients' Rooms | 1 | 2005 | 63 | 0.250 |
Why?
|
Imidazoles | 2 | 2008 | 1201 | 0.250 |
Why?
|
Arthroplasty, Replacement | 1 | 2008 | 341 | 0.240 |
Why?
|
Opioid-Related Disorders | 4 | 2021 | 2089 | 0.240 |
Why?
|
Cell Survival | 4 | 2013 | 5860 | 0.240 |
Why?
|
Neck Pain | 3 | 2006 | 179 | 0.230 |
Why?
|
Anesthetics, Local | 1 | 2011 | 990 | 0.230 |
Why?
|
Spinal Injuries | 2 | 2018 | 300 | 0.230 |
Why?
|
Disease Models, Animal | 12 | 2013 | 18174 | 0.230 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1748 | 0.230 |
Why?
|
Reference Values | 4 | 2013 | 4994 | 0.230 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2123 | 0.220 |
Why?
|
Prosthesis Failure | 1 | 2008 | 1213 | 0.220 |
Why?
|
Treatment Outcome | 22 | 2020 | 64017 | 0.220 |
Why?
|
Sunlight | 1 | 2005 | 330 | 0.220 |
Why?
|
Preoperative Care | 5 | 2020 | 2258 | 0.220 |
Why?
|
Inflammation | 3 | 2012 | 10751 | 0.220 |
Why?
|
Self Report | 1 | 2014 | 3618 | 0.220 |
Why?
|
Cattle | 4 | 2024 | 3926 | 0.210 |
Why?
|
Clinical Competence | 3 | 2023 | 4729 | 0.210 |
Why?
|
Coculture Techniques | 5 | 2012 | 1346 | 0.210 |
Why?
|
Diagnostic Imaging | 2 | 2009 | 3511 | 0.210 |
Why?
|
Bone Density | 3 | 2011 | 3504 | 0.210 |
Why?
|
Transplants | 1 | 2004 | 209 | 0.210 |
Why?
|
Fractures, Stress | 1 | 2004 | 189 | 0.210 |
Why?
|
Reoperation | 9 | 2022 | 4248 | 0.200 |
Why?
|
Lac Operon | 3 | 2008 | 239 | 0.200 |
Why?
|
Awards and Prizes | 3 | 2021 | 377 | 0.200 |
Why?
|
Gene Expression | 3 | 2010 | 7771 | 0.200 |
Why?
|
Collagen Type II | 4 | 2024 | 153 | 0.200 |
Why?
|
Bone Cements | 1 | 2003 | 330 | 0.200 |
Why?
|
Regeneration | 2 | 2017 | 1498 | 0.200 |
Why?
|
Interleukin-6 | 4 | 2008 | 3198 | 0.200 |
Why?
|
Imaging, Three-Dimensional | 2 | 2014 | 4041 | 0.190 |
Why?
|
Demography | 2 | 2023 | 1661 | 0.190 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2021 | 135 | 0.190 |
Why?
|
Nausea | 1 | 2004 | 675 | 0.190 |
Why?
|
Pain Insensitivity, Congenital | 1 | 2000 | 9 | 0.190 |
Why?
|
Analgesics | 2 | 2021 | 1041 | 0.180 |
Why?
|
Neck Injuries | 1 | 2002 | 157 | 0.180 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2491 | 0.180 |
Why?
|
Intraoperative Period | 4 | 2019 | 517 | 0.180 |
Why?
|
Smoking | 2 | 2011 | 9030 | 0.180 |
Why?
|
Quadriplegia | 1 | 2002 | 226 | 0.180 |
Why?
|
Surgical Wound Infection | 2 | 2020 | 1552 | 0.180 |
Why?
|
Accreditation | 1 | 2023 | 467 | 0.180 |
Why?
|
Aged, 80 and over | 18 | 2020 | 58361 | 0.180 |
Why?
|
Blood Transfusion | 2 | 2008 | 1319 | 0.170 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 786 | 0.170 |
Why?
|
Ataxia Telangiectasia | 1 | 2020 | 112 | 0.170 |
Why?
|
Compressive Strength | 3 | 2017 | 169 | 0.170 |
Why?
|
Epidural Abscess | 1 | 2020 | 86 | 0.170 |
Why?
|
Pyridines | 2 | 2008 | 2841 | 0.170 |
Why?
|
Monocytes | 1 | 2008 | 2602 | 0.170 |
Why?
|
Organ Culture Techniques | 2 | 2011 | 808 | 0.160 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3722 | 0.160 |
Why?
|
Delirium | 2 | 2020 | 1639 | 0.160 |
Why?
|
Bone Matrix | 2 | 1996 | 118 | 0.160 |
Why?
|
Osmotic Pressure | 1 | 2019 | 149 | 0.160 |
Why?
|
Tail | 1 | 2019 | 98 | 0.160 |
Why?
|
Cefazolin | 1 | 2019 | 97 | 0.160 |
Why?
|
Environment | 1 | 2005 | 1123 | 0.160 |
Why?
|
Postoperative Period | 5 | 2020 | 1848 | 0.160 |
Why?
|
Tissue Engineering | 2 | 2007 | 1893 | 0.160 |
Why?
|
Spondylolisthesis | 4 | 2018 | 158 | 0.160 |
Why?
|
Spondylosis | 2 | 2017 | 80 | 0.160 |
Why?
|
Ecosystem | 1 | 2022 | 485 | 0.160 |
Why?
|
Bone Screws | 2 | 2013 | 518 | 0.150 |
Why?
|
Fractures, Spontaneous | 1 | 2019 | 232 | 0.150 |
Why?
|
Lung Neoplasms | 2 | 2019 | 13263 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 11 | 2018 | 35798 | 0.150 |
Why?
|
Spinal Cord Compression | 1 | 2019 | 232 | 0.150 |
Why?
|
Signal Transduction | 6 | 2020 | 23512 | 0.150 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1190 | 0.150 |
Why?
|
Spinal Cord | 1 | 2006 | 1809 | 0.150 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2021 | 302 | 0.150 |
Why?
|
Cell Differentiation | 3 | 2009 | 11553 | 0.150 |
Why?
|
Incidence | 6 | 2020 | 21146 | 0.150 |
Why?
|
Abdominal Pain | 1 | 2004 | 1062 | 0.150 |
Why?
|
Policy | 1 | 2021 | 516 | 0.140 |
Why?
|
Recombinant Proteins | 5 | 2012 | 6624 | 0.140 |
Why?
|
Risk Adjustment | 1 | 2020 | 598 | 0.140 |
Why?
|
Injections, Spinal | 2 | 2008 | 305 | 0.140 |
Why?
|
Monitoring, Intraoperative | 3 | 2009 | 952 | 0.140 |
Why?
|
Mobility Limitation | 1 | 2020 | 413 | 0.140 |
Why?
|
Case-Control Studies | 7 | 2016 | 21904 | 0.140 |
Why?
|
Treatment Failure | 3 | 2019 | 2642 | 0.130 |
Why?
|
Transduction, Genetic | 3 | 2007 | 905 | 0.130 |
Why?
|
Vancomycin | 1 | 2019 | 501 | 0.130 |
Why?
|
Health Status | 4 | 2019 | 4077 | 0.130 |
Why?
|
Walking | 2 | 2022 | 1192 | 0.130 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4943 | 0.130 |
Why?
|
Ligaments, Articular | 2 | 2016 | 303 | 0.130 |
Why?
|
Ilium | 1 | 2016 | 153 | 0.130 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2006 | 248 | 0.120 |
Why?
|
Cell Culture Techniques | 3 | 2009 | 1680 | 0.120 |
Why?
|
Risk Factors | 16 | 2020 | 73094 | 0.120 |
Why?
|
Telemedicine | 2 | 2022 | 2990 | 0.120 |
Why?
|
Cell-Derived Microparticles | 1 | 2016 | 167 | 0.120 |
Why?
|
Green Fluorescent Proteins | 3 | 2012 | 2080 | 0.120 |
Why?
|
Osteoporosis | 2 | 2003 | 1582 | 0.120 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 2 | 2005 | 17 | 0.120 |
Why?
|
Spinal Curvatures | 1 | 2015 | 67 | 0.120 |
Why?
|
Amyloidosis | 1 | 2021 | 808 | 0.120 |
Why?
|
Geriatric Assessment | 2 | 2020 | 1390 | 0.120 |
Why?
|
Cohort Studies | 11 | 2022 | 40939 | 0.120 |
Why?
|
Macrophages | 1 | 2008 | 5710 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2019 | 647 | 0.110 |
Why?
|
Culture Media, Conditioned | 3 | 2012 | 534 | 0.110 |
Why?
|
Occupational Health | 1 | 2020 | 807 | 0.110 |
Why?
|
Communicable Disease Control | 1 | 2020 | 862 | 0.110 |
Why?
|
RNA, Messenger | 4 | 2010 | 13011 | 0.110 |
Why?
|
Algorithms | 6 | 2020 | 13984 | 0.110 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2008 | 647 | 0.110 |
Why?
|
Models, Biological | 3 | 2019 | 9569 | 0.110 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2019 | 1119 | 0.110 |
Why?
|
Sensitivity and Specificity | 5 | 2012 | 14761 | 0.110 |
Why?
|
Tissue and Organ Harvesting | 1 | 2016 | 367 | 0.110 |
Why?
|
Length of Stay | 3 | 2021 | 6355 | 0.110 |
Why?
|
Cyclooxygenase 2 | 2 | 2015 | 612 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3136 | 0.100 |
Why?
|
NF-kappa B | 3 | 2021 | 2495 | 0.100 |
Why?
|
Prospective Studies | 13 | 2022 | 53863 | 0.100 |
Why?
|
Peptide Hydrolases | 1 | 2015 | 633 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3246 | 0.100 |
Why?
|
Muscles | 2 | 2015 | 1618 | 0.100 |
Why?
|
Athletic Injuries | 1 | 2002 | 1155 | 0.100 |
Why?
|
Prone Position | 1 | 2012 | 194 | 0.100 |
Why?
|
Patella | 1 | 1993 | 323 | 0.100 |
Why?
|
Reproducibility of Results | 6 | 2015 | 20026 | 0.100 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4881 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1380 | 0.100 |
Why?
|
Up-Regulation | 2 | 2013 | 4194 | 0.100 |
Why?
|
Diagnostic Techniques, Surgical | 1 | 2010 | 10 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 1 | 2007 | 5584 | 0.100 |
Why?
|
Staphylococcal Infections | 1 | 2020 | 1405 | 0.100 |
Why?
|
Tantalum | 1 | 2011 | 56 | 0.100 |
Why?
|
Decompression | 2 | 2020 | 42 | 0.090 |
Why?
|
Autophagy | 1 | 2019 | 1308 | 0.090 |
Why?
|
Benchmarking | 1 | 2017 | 1048 | 0.090 |
Why?
|
Child | 3 | 2023 | 78594 | 0.090 |
Why?
|
Biopsy, Needle | 2 | 2006 | 1642 | 0.090 |
Why?
|
Dinoprost | 1 | 2010 | 139 | 0.090 |
Why?
|
DNA Damage | 1 | 2020 | 2442 | 0.090 |
Why?
|
Acetabulum | 2 | 1992 | 531 | 0.090 |
Why?
|
Knee Prosthesis | 1 | 1993 | 424 | 0.090 |
Why?
|
Deglutition | 1 | 2011 | 204 | 0.090 |
Why?
|
Immunohistochemistry | 4 | 2009 | 11395 | 0.090 |
Why?
|
Quality of Life | 5 | 2022 | 13044 | 0.090 |
Why?
|
Contracture | 1 | 2012 | 228 | 0.090 |
Why?
|
Young Adult | 7 | 2018 | 57267 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15164 | 0.090 |
Why?
|
Feasibility Studies | 3 | 2009 | 5144 | 0.080 |
Why?
|
Cell Proliferation | 2 | 2024 | 10508 | 0.080 |
Why?
|
SOX9 Transcription Factor | 1 | 2009 | 147 | 0.080 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2010 | 532 | 0.080 |
Why?
|
Nerve Growth Factors | 1 | 2012 | 573 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2012 | 4420 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 13042 | 0.080 |
Why?
|
Medical History Taking | 1 | 2012 | 782 | 0.080 |
Why?
|
Cell Shape | 1 | 2009 | 383 | 0.080 |
Why?
|
Neovascularization, Pathologic | 2 | 2016 | 2654 | 0.080 |
Why?
|
Physical Examination | 2 | 2012 | 1237 | 0.080 |
Why?
|
Hip Prosthesis | 2 | 1992 | 920 | 0.080 |
Why?
|
Risk Assessment | 5 | 2020 | 23554 | 0.080 |
Why?
|
Hexuronic Acids | 1 | 2007 | 145 | 0.080 |
Why?
|
Glucuronic Acid | 1 | 2007 | 149 | 0.080 |
Why?
|
Random Allocation | 1 | 2012 | 2426 | 0.080 |
Why?
|
Carcinoma | 1 | 2019 | 2385 | 0.080 |
Why?
|
Consultants | 1 | 2007 | 53 | 0.080 |
Why?
|
Liver Diseases | 1 | 2016 | 1264 | 0.080 |
Why?
|
Polyradiculopathy | 1 | 2007 | 23 | 0.080 |
Why?
|
Cell Fusion | 1 | 2008 | 296 | 0.080 |
Why?
|
Angiography, Digital Subtraction | 1 | 2009 | 339 | 0.070 |
Why?
|
Braces | 1 | 2008 | 140 | 0.070 |
Why?
|
Epidural Space | 1 | 2008 | 123 | 0.070 |
Why?
|
Mechanotransduction, Cellular | 1 | 2012 | 541 | 0.070 |
Why?
|
Spinal Canal | 1 | 2007 | 39 | 0.070 |
Why?
|
Disease Progression | 6 | 2017 | 13364 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2008 | 5974 | 0.070 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2007 | 36 | 0.070 |
Why?
|
Fas Ligand Protein | 1 | 2007 | 216 | 0.070 |
Why?
|
Rupture | 1 | 2008 | 434 | 0.070 |
Why?
|
Restraint, Physical | 1 | 2008 | 193 | 0.070 |
Why?
|
Age Factors | 5 | 2020 | 18460 | 0.070 |
Why?
|
Prognosis | 6 | 2020 | 29264 | 0.070 |
Why?
|
Arteries | 1 | 2011 | 1123 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2013 | 824 | 0.070 |
Why?
|
Tissue Donors | 1 | 2016 | 2234 | 0.070 |
Why?
|
Pilot Projects | 2 | 2012 | 8413 | 0.070 |
Why?
|
Equipment Failure | 1 | 2009 | 579 | 0.070 |
Why?
|
Alginates | 1 | 2007 | 253 | 0.070 |
Why?
|
Arthroplasty | 1 | 2009 | 306 | 0.070 |
Why?
|
Medical Illustration | 1 | 2007 | 134 | 0.070 |
Why?
|
Interleukin-1beta | 2 | 2012 | 989 | 0.070 |
Why?
|
Time Factors | 6 | 2011 | 40195 | 0.070 |
Why?
|
Decision Making | 1 | 2020 | 3909 | 0.070 |
Why?
|
Magnetics | 1 | 2008 | 605 | 0.070 |
Why?
|
Severity of Illness Index | 4 | 2011 | 15657 | 0.070 |
Why?
|
Adult Stem Cells | 1 | 2007 | 217 | 0.070 |
Why?
|
Deglutition Disorders | 1 | 2011 | 614 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 1919 | 0.070 |
Why?
|
Industry | 1 | 2007 | 365 | 0.060 |
Why?
|
Logistic Models | 2 | 2019 | 13441 | 0.060 |
Why?
|
Culture Techniques | 2 | 1996 | 550 | 0.060 |
Why?
|
Buttocks | 1 | 2005 | 114 | 0.060 |
Why?
|
Biomedical Technology | 1 | 2007 | 224 | 0.060 |
Why?
|
Equipment and Supplies | 1 | 2007 | 283 | 0.060 |
Why?
|
Immunocompetence | 1 | 2005 | 138 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2019 | 3374 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2011 | 1447 | 0.060 |
Why?
|
Chondrocytes | 1 | 2009 | 804 | 0.060 |
Why?
|
Neck | 3 | 2012 | 713 | 0.060 |
Why?
|
Stress, Physiological | 1 | 2011 | 1402 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2024 | 70 | 0.060 |
Why?
|
Hospital Units | 1 | 2005 | 141 | 0.060 |
Why?
|
Osteogenesis | 1 | 1991 | 1295 | 0.060 |
Why?
|
Postoperative Hemorrhage | 1 | 2007 | 412 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2011 | 39223 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2016 | 3518 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8607 | 0.060 |
Why?
|
Adolescent | 7 | 2019 | 86713 | 0.050 |
Why?
|
Conflict of Interest | 1 | 2007 | 550 | 0.050 |
Why?
|
Shoulder Pain | 1 | 2003 | 145 | 0.050 |
Why?
|
Fracture Healing | 1 | 2005 | 433 | 0.050 |
Why?
|
Growth Substances | 1 | 2004 | 783 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2015 | 1770 | 0.050 |
Why?
|
Molecular Biology | 1 | 2006 | 591 | 0.050 |
Why?
|
Collagen | 2 | 2009 | 2689 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2007 | 12054 | 0.050 |
Why?
|
Plasmids | 1 | 2007 | 2316 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2008 | 2606 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 914 | 0.050 |
Why?
|
Equipment Design | 2 | 2008 | 3589 | 0.050 |
Why?
|
Hydroxyapatites | 2 | 1992 | 75 | 0.050 |
Why?
|
Gene Targeting | 1 | 2005 | 874 | 0.050 |
Why?
|
Psychometrics | 1 | 2010 | 3014 | 0.050 |
Why?
|
Biochemical Phenomena | 1 | 2001 | 58 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2004 | 1118 | 0.050 |
Why?
|
Mice | 7 | 2020 | 81766 | 0.050 |
Why?
|
Prevalence | 5 | 2015 | 15404 | 0.050 |
Why?
|
Artifacts | 1 | 2009 | 1905 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2000 | 76 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8422 | 0.050 |
Why?
|
Patients | 1 | 2007 | 904 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2023 | 471 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7269 | 0.050 |
Why?
|
Physician's Role | 1 | 2007 | 940 | 0.050 |
Why?
|
Cell Communication | 1 | 2007 | 1639 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14219 | 0.050 |
Why?
|
Biochemistry | 1 | 2001 | 114 | 0.050 |
Why?
|
Hematocrit | 1 | 2002 | 636 | 0.050 |
Why?
|
Peptides | 1 | 2012 | 4430 | 0.050 |
Why?
|
Sex Distribution | 2 | 2003 | 2304 | 0.040 |
Why?
|
Spasm | 1 | 2000 | 129 | 0.040 |
Why?
|
Cerebral Palsy | 1 | 2004 | 464 | 0.040 |
Why?
|
Postoperative Care | 1 | 2006 | 1497 | 0.040 |
Why?
|
Iatrogenic Disease | 3 | 2009 | 546 | 0.040 |
Why?
|
Blood Donors | 1 | 2002 | 355 | 0.040 |
Why?
|
Social Behavior | 1 | 2006 | 1132 | 0.040 |
Why?
|
Age Distribution | 2 | 2003 | 2905 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8660 | 0.040 |
Why?
|
Models, Animal | 1 | 2006 | 2175 | 0.040 |
Why?
|
Subarachnoid Space | 1 | 1999 | 79 | 0.040 |
Why?
|
Time | 1 | 2020 | 548 | 0.040 |
Why?
|
Nerve Compression Syndromes | 1 | 2000 | 161 | 0.040 |
Why?
|
Anabolic Agents | 1 | 2021 | 246 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 798 | 0.040 |
Why?
|
Inpatients | 2 | 2020 | 2549 | 0.040 |
Why?
|
England | 1 | 2020 | 528 | 0.040 |
Why?
|
Luciferases | 1 | 2000 | 732 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10914 | 0.040 |
Why?
|
Mortality | 2 | 2020 | 2899 | 0.040 |
Why?
|
Information Systems | 1 | 2020 | 410 | 0.040 |
Why?
|
Specialty Boards | 1 | 2020 | 231 | 0.040 |
Why?
|
Genetic Markers | 1 | 2005 | 2633 | 0.040 |
Why?
|
Tendons | 2 | 2021 | 555 | 0.040 |
Why?
|
Gelatinases | 2 | 1996 | 93 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 258 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 7970 | 0.040 |
Why?
|
Joints | 1 | 1999 | 328 | 0.040 |
Why?
|
Retroviridae | 1 | 2000 | 914 | 0.040 |
Why?
|
Back Pain | 1 | 2002 | 546 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12250 | 0.040 |
Why?
|
omega-N-Methylarginine | 1 | 1997 | 112 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2019 | 788 | 0.040 |
Why?
|
Linear Models | 3 | 2003 | 5965 | 0.040 |
Why?
|
Certification | 1 | 2021 | 428 | 0.040 |
Why?
|
Culture Media | 1 | 2019 | 908 | 0.040 |
Why?
|
Platelet Count | 1 | 2019 | 784 | 0.040 |
Why?
|
Drug Costs | 1 | 2005 | 1117 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 18050 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3871 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2000 | 1544 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13678 | 0.030 |
Why?
|
Cell Count | 1 | 2000 | 1856 | 0.030 |
Why?
|
Phosphorylation | 1 | 2007 | 8414 | 0.030 |
Why?
|
Football | 1 | 2002 | 465 | 0.030 |
Why?
|
General Surgery | 1 | 2007 | 1645 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6364 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7805 | 0.030 |
Why?
|
Cerebrospinal Fluid | 1 | 1999 | 532 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 16789 | 0.030 |
Why?
|
Frail Elderly | 1 | 2020 | 696 | 0.030 |
Why?
|
Microscopy, Fluorescence | 2 | 2013 | 2702 | 0.030 |
Why?
|
Pressure | 1 | 2019 | 1207 | 0.030 |
Why?
|
Enzyme Induction | 1 | 1996 | 472 | 0.030 |
Why?
|
Transfection | 1 | 2003 | 5882 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2010 | 4316 | 0.030 |
Why?
|
Biopsy | 1 | 2007 | 6771 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1784 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 844 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8971 | 0.030 |
Why?
|
Emotions | 1 | 2006 | 2684 | 0.030 |
Why?
|
Safety Management | 1 | 2020 | 782 | 0.030 |
Why?
|
Sheep | 1 | 2017 | 1445 | 0.030 |
Why?
|
Fee-for-Service Plans | 1 | 2019 | 700 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 927 | 0.030 |
Why?
|
Base Sequence | 1 | 2005 | 12769 | 0.030 |
Why?
|
Catheterization | 1 | 1999 | 1467 | 0.030 |
Why?
|
Forecasting | 1 | 2022 | 2956 | 0.030 |
Why?
|
Drainage | 1 | 1999 | 1147 | 0.030 |
Why?
|
Posterior Cruciate Ligament | 1 | 1993 | 89 | 0.030 |
Why?
|
Comorbidity | 2 | 2011 | 10450 | 0.030 |
Why?
|
Cross-Sectional Studies | 5 | 2013 | 25454 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3023 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2007 | 4929 | 0.030 |
Why?
|
Neurons | 1 | 2012 | 9439 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20914 | 0.030 |
Why?
|
Mental Health | 1 | 2006 | 3074 | 0.030 |
Why?
|
Phenotype | 1 | 2009 | 16484 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2332 | 0.030 |
Why?
|
Scoliosis | 1 | 1998 | 739 | 0.020 |
Why?
|
Cadaver | 1 | 2015 | 1353 | 0.020 |
Why?
|
Recovery of Function | 1 | 2002 | 2950 | 0.020 |
Why?
|
I-kappa B Kinase | 1 | 2012 | 245 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2012 | 268 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 2018 | 799 | 0.020 |
Why?
|
Versicans | 1 | 2010 | 33 | 0.020 |
Why?
|
Propensity Score | 1 | 2018 | 1828 | 0.020 |
Why?
|
Off-Label Use | 1 | 2012 | 181 | 0.020 |
Why?
|
Mental Disorders | 1 | 2010 | 6699 | 0.020 |
Why?
|
Disability Evaluation | 2 | 2012 | 1842 | 0.020 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2010 | 140 | 0.020 |
Why?
|
Lymphoma | 1 | 2019 | 1892 | 0.020 |
Why?
|
Ceramics | 1 | 1991 | 106 | 0.020 |
Why?
|
Head | 1 | 2015 | 898 | 0.020 |
Why?
|
Calcium Phosphates | 1 | 1991 | 171 | 0.020 |
Why?
|
Neurites | 1 | 2012 | 386 | 0.020 |
Why?
|
Endonucleases | 1 | 2012 | 379 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3433 | 0.020 |
Why?
|
Dogs | 2 | 1992 | 3915 | 0.020 |
Why?
|
Arachidonic Acid | 1 | 2010 | 435 | 0.020 |
Why?
|
Chronic Disease | 1 | 2004 | 9223 | 0.020 |
Why?
|
Tretinoin | 1 | 2012 | 528 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2012 | 693 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6493 | 0.020 |
Why?
|
Collagen Type I | 1 | 2010 | 592 | 0.020 |
Why?
|
Social Control, Formal | 1 | 2007 | 110 | 0.020 |
Why?
|
Oxygen | 1 | 2019 | 4208 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22009 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12202 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
Government | 1 | 2007 | 167 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1997 | 3766 | 0.020 |
Why?
|
Health Expenditures | 1 | 2019 | 2371 | 0.020 |
Why?
|
Pennsylvania | 1 | 2007 | 612 | 0.020 |
Why?
|
Medical Audit | 1 | 2007 | 466 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2012 | 1402 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6318 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 1991 | 2125 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2015 | 1295 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4579 | 0.020 |
Why?
|
Femur | 1 | 1992 | 1308 | 0.020 |
Why?
|
Wounds, Stab | 1 | 2005 | 71 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1670 | 0.020 |
Why?
|
Knee Joint | 1 | 1993 | 1709 | 0.020 |
Why?
|
Glycosaminoglycans | 1 | 2007 | 628 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5380 | 0.010 |
Why?
|
Infant | 1 | 2006 | 35447 | 0.010 |
Why?
|
Arthrography | 1 | 2005 | 152 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4311 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2012 | 1242 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 1626 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7355 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9657 | 0.010 |
Why?
|
Observer Variation | 1 | 2008 | 2622 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2675 | 0.010 |
Why?
|
Depression | 1 | 2002 | 7876 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3753 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2481 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 16004 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2019 | 5076 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1270 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2008 | 1432 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1690 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 1988 | 1390 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2798 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13778 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2012 | 2776 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2287 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9743 | 0.010 |
Why?
|
Educational Status | 1 | 2007 | 2573 | 0.010 |
Why?
|
Orthopedic Fixation Devices | 1 | 1999 | 75 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5338 | 0.010 |
Why?
|
Income | 1 | 2007 | 1921 | 0.010 |
Why?
|
Data Collection | 1 | 2007 | 3350 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1993 | 3766 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14596 | 0.010 |
Why?
|
Calibration | 1 | 1999 | 820 | 0.010 |
Why?
|
Nonlinear Dynamics | 1 | 1999 | 500 | 0.010 |
Why?
|
Wounds, Penetrating | 1 | 1999 | 307 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1999 | 430 | 0.010 |
Why?
|
Disease Management | 1 | 2006 | 2473 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9664 | 0.010 |
Why?
|
Body Composition | 1 | 2003 | 2439 | 0.010 |
Why?
|
Hospitals | 1 | 2007 | 3986 | 0.010 |
Why?
|
Pepsin A | 1 | 1988 | 71 | 0.010 |
Why?
|
Microbial Collagenase | 1 | 1988 | 122 | 0.000 |
Why?
|
Proteins | 1 | 2003 | 6093 | 0.000 |
Why?
|
Fractures, Bone | 1 | 1999 | 1991 | 0.000 |
Why?
|
Synovial Fluid | 1 | 1988 | 403 | 0.000 |
Why?
|
Cartilage | 1 | 1988 | 818 | 0.000 |
Why?
|
Arthritis | 1 | 1988 | 667 | 0.000 |
Why?
|
Bone Marrow | 1 | 1992 | 2945 | 0.000 |
Why?
|